Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
Braz. j. infect. dis ; 20(4): 360-364, July-Aug. 2016. tab, graf
Article Dans Anglais | LILACS | ID: biblio-828122

Résumé

Abstract JC virus (JCV) is a member of the Polyomaviridae family and is associated to a severe disease known as progressive multifocal leukoencephalopathy, PML, which is gradually increasing in incidence as an opportunistic infection among AIDS patients. The present study aimed to investigate the occurrence of JCV among HIV-1 carriers including their types and molecular subtypes and the possible association with disease. Urine samples from 66 HIV-1 infected subjects were investigated for the presence of the virus by amplifying VP1 (215 bp) and IG (610 bp) regions using the polymerase chain reaction. JCV was detected in 32% of the samples. The results confirmed the occurrence of type B (subtype Af2); in addition, another polyomavirus, BKV, was also detected in 1.5% of samples of the HIV-1 infected subjects. Apparently, there was no significant difference between mono- (HIV-1 only) and co-infected (HIV-1/JCV) subjects regarding their TCD4+/TCD8+ lymphocyte counts or HIV-1 plasma viral load. Self admitted seizures, hearing and visual loses were not significantly different between the two groups.


Sujets)
Humains , Mâle , Femelle , Enfant , Adolescent , Adulte , Adulte d'âge moyen , Jeune adulte , Leucoencéphalopathie multifocale progressive/diagnostic , Infections opportunistes liées au SIDA/virologie , Virus JC/génétique , ADN viral/urine , Réaction de polymérisation en chaîne , Études transversales , Infections opportunistes liées au SIDA/diagnostic , Infections opportunistes liées au SIDA/urine , Virus JC/isolement et purification , Numération des lymphocytes CD4 , Charge virale , Co-infection/virologie
2.
Mem. Inst. Oswaldo Cruz ; 110(7): 825-830, Nov. 2015. tab, graf
Article Dans Anglais | LILACS | ID: lil-764590

Résumé

We refer to Oswaldo Cruz’s reports dating from 1913 about the necessities of a healthcare system for the Brazilian Amazon Region and about the journey of Carlos Chagas to 27 locations in this region and the measures that would need to be adopted. We discuss the risks of endemicity of Chagas disease in the Amazon Region. We recommend that epidemiological surveillance of Chagas disease in the Brazilian Amazon Region and Pan-Amazon region should be implemented through continuous monitoring of the human population that lives in the area, their housing, the environment and the presence of triatomines. The monitoring should be performed with periodic seroepidemiological surveys, semi-annual visits to homes by health agents and the training of malaria microscopists and healthcare technicians to identify Trypanosoma cruzifrom patients’ samples and T. cruziinfection rates among the triatomines caught. We recommend health promotion and control of Chagas disease through public health policies, especially through sanitary education regarding the risk factors for Chagas disease. Finally, we propose a healthcare system through base hospitals, intermediate-level units in the areas of the Brazilian Amazon Region and air transportation, considering the distances to be covered for medical care.


Sujets)
Animaux , Humains , Maladie de Chagas , Promotion de la santé , Surveillance de la population , Brésil/épidémiologie , Maladie de Chagas/épidémiologie , Maladie de Chagas/prévention et contrôle , Maladie de Chagas/transmission , Maladies endémiques , Vecteurs insectes/classification , Facteurs de risque , Triatominae/classification
3.
Rev. Soc. Bras. Med. Trop ; 41(6): 596-601, Nov.-Dec. 2008. ilus, tab
Article Dans Portugais | LILACS | ID: lil-502041

Résumé

Recentemente é descrito estado de persistência do vírus da hepatite B denominado hepatite crônica B oculta. Sua prevalência e fisiopatologia são desconhecidas. O objetivo deste estudo foi avaliar a ocorrência dessa entidade clínica em pacientes da Amazônia brasileira. De 51 pacientes anti-HBc total reativos testados pela reação em cadeia da polimerase, 17 por cento foram positivos. Não observamos associação com fatores de risco clássicos de infecção pelo vírus da hepatite B, testes bioquímicos, hematológicos e histopatologia. No entanto, os pacientes ictéricos e reativos para o anti-HIV apresentaram associação com a presença do ADN-vírus da hepatite B. Os resultados demonstram a ocorrência da hepatite crônica B oculta, entre nossos doentes, porém, com taxas de prevalência abaixo do esperado para a região. Acreditamos que, apesar do tamanho da amostra avaliada ser pequeno, sua ocorrência poderia ter sido maior se empregássemos primers para a região S, C e X do genoma do vírus da hepatite B, aumentando a sensibilidade do teste.


A persistent form of the hepatitis B virus called occult chronic hepatitis B has recently been described. Its prevalence and physiopathology are unknown. The aim of this study was to evaluate the occurrence of this clinical entity among patients in the Brazilian Amazon region. Out of 51 anti-HBc total-positive patients who were tested using the polymerase chain reaction, 17 percent were positive. We did not find any associations with classical risk factors for hepatitis B virus infection or with biochemical tests, hematological tests or histological patterns. However, the jaundiced and HIV-positive patients showed a statistical association with the presence of hepatitis B virus-DNA. The results demonstrated that occult hepatitis B occurred among our patients, but at prevalence rates lower than expected for this region. We believe that despite the small sample size, the occurrence might have been found to be greater if we had used primers for the S, C and X regions of the hepatitis B virus genome, thereby increasing the sensitivity of the test.


Sujets)
Femelle , Humains , Mâle , Maladies endémiques , Anticorps de l'hépatite B/sang , Antigènes de la nucléocapside du virus de l'hépatite virale B/immunologie , Virus de l'hépatite B/isolement et purification , Hépatite B chronique/épidémiologie , Brésil/épidémiologie , ADN viral/analyse , Virus de l'hépatite B/génétique , Virus de l'hépatite B/immunologie , Hépatite B chronique/diagnostic , Réaction de polymérisation en chaîne , Prévalence , Études prospectives , Facteurs de risque
4.
Genet. mol. res. (Online) ; 7(1): 60-64, Jan. 2008. tab
Article Dans Anglais | LILACS | ID: lil-553771

Résumé

Malaria is an endemic parasitosis and its causitive agent, Plasmodium, has a metabolism linked to iron supply. HFE is a gene with the polymorphisms C282Y and H63D, which are associated with a progressive iron accumulation in the organism leading to a disease called hereditary hemochromatosis. The aim of the present study was to determine the allelic and genotypic frequencies of the HFE gene polymorphisms in malaria patients and blood donors from the Brazilian Amazon region. We screened 400 blood donors and 400 malaria patients for the HFE C282Y and H63D polymorphisms from four states of the Brazilian Amazon region by polymerase chain reaction and restriction fragment length polymorphism analysis. We did not find any C282Y homozygous individuals, and the only five heterozygous individuals detected were from Pará State. The most frequent genotype in the North region of Brazil was the H63D heterozygote, in both study groups. Our results contribute to the concept that the Brazilian Amazon region should not be regarded as a single entity in South America. These polymorphisms did not influence the symptoms of malaria in the population studied, as neither severe signs nor high parasitemia were observed. Therefore, different hereditary hemochromatosis diagnostic and control measures must be developed and applied within its diverse locations. Investigations are currently being carried out in our laboratory in order to determine the importance of the coexistence of hereditary hemochromatosis in patients affected by parasitic diseases, such as malaria.


Sujets)
Humains , Animaux , Femelle , Adulte , Fréquence d'allèle , Paludisme/génétique , Polymorphisme génétique , Allèles , Brésil/épidémiologie , Études cas-témoins , Maladies endémiques , Hétérozygote , Paludisme/épidémiologie , Paludisme/parasitologie , Paludisme/sang , Prévalence , Plasmodium falciparum/parasitologie , Plasmodium vivax/parasitologie
SÉLECTION CITATIONS
Détails de la recherche